Related references
Note: Only part of the references are listed.Antibody inhibition of human cytomegalovirus spread in epithelial cell cultures
Xiaohong Cui et al.
JOURNAL OF VIROLOGICAL METHODS (2013)
Human Cytomegalovirus (HCMV) Glycoprotein gB Promotes Virus Entry In Trans Acting as the Viral Fusion Protein Rather than as a Receptor-Binding Protein
Paul T. Wille et al.
MBIO (2013)
Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin
Ashley E. Fouts et al.
JOURNAL OF VIROLOGY (2012)
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
Mohamed A. Kharfan-Dabaja et al.
LANCET INFECTIOUS DISEASES (2012)
Neutralizing Activity of Saliva against Cytomegalovirus
Frances M. Saccoccio et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells
Frances M. Saccoccio et al.
VACCINE (2011)
Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex
Annalisa Macagno et al.
JOURNAL OF VIROLOGY (2010)
Vaccine Prevention of Maternal Cytomegalovirus Infection
Robert F. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
Xiaohong Cui et al.
VACCINE (2008)
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus
Elizabeth A. Reap et al.
VACCINE (2007)
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines
TC Heineman et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response
M Shimamura et al.
JOURNAL OF VIROLOGY (2006)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genetic content of wild-type human cytomegalovirus
A Dolan et al.
JOURNAL OF GENERAL VIROLOGY (2004)